Ignite Creation Date:
2024-05-05 @ 5:23 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00444015
Status:
COMPLETED
Last Update Posted:
2017-02-23
First Post:
2007-03-05
Brief Title:
Phase I DasatinibErlotinib in Recurrent Non-small Cell Lung Cancer NSCLC
Sponsor:
Organization:
H Lee Moffitt Cancer Center and Research Institute